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Abstract
Background: In proteomics, batch effects are technical sources of variation that confounds proper analysis,
preventing effective deployment in clinical and translational research.
Results: Using simulated and real data, we demonstrate existing batch effect-correction methods do not always
eradicate all batch effects. Worse still, they may alter data integrity, and introduce false positives. Moreover,
although Principal component analysis (PCA) is commonly used for detecting batch effects. The principal
components (PCs) themselves may be used as differential features, from which relevant differential proteins may be
effectively traced. Batch effect are removable by identifying PCs highly correlated with batch but not class effect.
However, neither PC-based nor existing batch effect-correction methods address well subtle batch effects, which
are difficult to eradicate, and involve data transformation and/or projection which is error-prone. To address this, we
introduce the concept of batch-effect resistant methods and demonstrate how such methods incorporating protein
complexes are particularly resistant to batch effect without compromising data integrity.
Conclusions: Protein complex-based analyses are powerful, offering unparalleled differential protein-selection
reproducibility and high prediction accuracy. We demonstrate for the first time their innate resistance against batch
effects, even subtle ones. As complex-based analyses require no prior data transformation (e.g. batch-effect
correction), data integrity is protected. Individual checks on top-ranked protein complexes confirm strong
association with phenotype classes and not batch. Therefore, the constituent proteins of these complexes are more
likely to be clinically relevant.
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Background
The emergence of high-performance protein-extraction
procedures (e.g., PCT [1]), brute-force spectra-capture
methods (e.g., SWATH [2]), and improved multiplexing
technologies [3] has transformed proteomics (the high-
throughput expressional study of proteins) from a rela-
tively low-throughput technology to one with critical
practical applications in biology.
The application of proteomics on clinical samples
(i.e., clinical proteomics) is concerned with unraveling
proteome changes associated with disease using actual
clinical samples. Typically, two classes of samples—
e.g., normal (D) and disease (D*)—are compared
against each other. Proteins exhibiting strong inter-
class differences are marked as differential and ana-
lyzed for relevant functional roles. Statistics provides
powerful means for differential protein selection based
on the hypothesis-testing framework. This process is
commonly referred to as “feature selection” (where a
feature is a protein in this instance; see Methods for
details on feature selection).
Unfortunately, despite increasing ease in data generation,
extracting knowledge from proteomics expression data is
difficult [4]. Proper feature selection, if done correctly,
should lead directly to drug-target and biomarker identifi-
cation; but in practice, this is seldom the case [5, 6].
In theory, a strongly differential feature (e.g., a protein)
should exhibit strong inter-class differences across samples.
However, real samples are intrinsically noisy. This intrinsic
noise is random (unstructured) and obfuscates proper fea-
ture selection by masking true inter-class differences. The
manner in which the samples are prepared contributes to-
wards a second type of variation, which unlike intrinsic ran-
dom noise, is non-random (structured) and not associated
with class effects; i.e., they do not distinguish sample classes
D and D* specifically. This second source of variation,
where features are more strongly correlated with technical
factors (time of experiment, technician, reagent vendor, in-
strument, etc.) than with sample classes (e.g., D and D*)
[7–10], is referred to as batch effects.
It is not straightforward to distinguish batch and class
effects: When the former is mild, it may lead to bias dur-
ing feature selection; but when strong, lead to downright
selection of irrelevant proteins that confound and mis-
lead (i.e., false positives) and/or the loss of truly relevant
proteins (i.e., false negatives). In other words, batch ef-
fects obfuscate analysis. Batch effects are known to be
present in genomics assays [7–9]. However, they are a
nuisance in proteomics assays, where multiplexing limits
impose constraints on the number of samples for con-
current analysis; e.g., analyzing eight samples with the
commonly used 4-plex iTRAQ labeling system requires
at least two separate experiments performed at different
times, or on different instruments.
Despite fairly recent work demonstrating that batch-
effect correction may lead to substantial increase in
feature-selection sensitivity [11], a systematic explor-
ation of batch effects in proteomics data, and proposal
of feasible workarounds, is missing. Reasons include
underestimating heterogeneity in practical usage (as-
suming that class effects dominate variation), unsuit-
able data (data are already match-paired as ratios and
thus, classes cannot be distinguished from each other),
and the erroneous belief that normalization eradicates
batch effects. Normalization is a data processing tech-
nique that adjusts global properties of measurements
for individual samples for appropriate comparisons.
Examples include z- and quantile-normalization, and
mean-scaling. However, normalization cannot eradi-
cate batch effects, as the latter does not affect all
variables similarly [10]. In cases where statistical as-
sumptions are violated, normalization may affect data
integrity instead.
Batch effects are usually detected via principal compo-
nent analysis (PCA), where the first two or three princi-
pal components (PCs) are plotted for each sample
colored by the batch labels, and separation of colors
taken as evidence of batch effects [12]. When batch
effects are dominant, the first n PCs are expected to be
dominated by batch effects, and removal of these PCs
may be an alternative yet effective means of batch-effect
correction. The remaining PCs—though these have
lower contribution towards overall variation—may be
dominated by small subsets of variables with good class-
discrimination power [13]. Thus, feature selection at the
level of PCs—i.e., using PCs, as opposed to proteins, as
features—may be a viable batch effect-resistant feature-
selection strategy.
Protein complex-based analysis, as a new analytical
paradigm, provides a powerful yet stable means of
selecting features, at the level of protein complexes,
from proteomics data [14–17]. Protein complexes are
strongly enriched for biological coherence signal [18],
beating any combinations of alternative measurements
(expression correlation, GO-term overlaps, etc.) Using
protein complex-based analysis, we have successfully re-
covered missing proteins [17] and overcome consistency
issues where patient samples present widely different
protein sets [19–21]. Protein complex-based analysis
also exhibits unparalleled stability and reproducibility in
feature selection [14, 22, 23]. We hypothesize that this
superior performance may stem in part, from innate re-
sistance to batch effects.
We address the following gaps in batch effects, and its
implications for feature selection in a proteomics setting.
First, we propose a simple technique for simulating
batch effects in proteomics data, and recommend using
it for evaluating feature-selection procedures, as well as
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checking whether batch effect-correction algorithms are
working as intended. Second, while PCA is the de facto
approach for visualizing presence of batch effects, we in-
vestigate its feasibility as a feature-selection technique
where features are principal components (PCs) instead
of proteins. And finally, as a potential new advantage
(which is never reported before), we check whether
protein complex-based feature-selection algorithms are
truly resistant to batch effects; and if so, whether they
may supersede the need for batch effect-correction
algorithms.
Methods
Simulated data — D2.2 and D2.2H (Simulated batch
effect)
We used part of the D2.2 dataset (301 to 400) from the
study of Langley and Mayr as a reference proteomics
simulation dataset where differential variables are known
a priori [24] (four samples in class D and D* respect-
ively). Quantitation is based on spectral counts.
Class effects and batch effects are inserted randomly,
with the increase made in D* samples only. Simulated
data with both class and batch effects inserted is referred
to as D2.2H, while the original data with only class
effects is referred to as D2.2 (Additional file 1).
Real data — Renal cancer (RC) (Real batch effect)
The renal cancer (RC) study of Guo et al. [1] comprises
a total of 24 SWATH runs originating from six pairs of
non-tumorous and tumorous clear-cell renal cell carcin-
oma (ccRCC) tissues, in two batches, rep1 and rep2
(Additional file 1).
Batch effect-correction methods
For batch-effect correction, we used quantile
normalization and linear-scaling as generic approaches
(Additional file 1). Quantile normalization and linear-
scaling are not explicitly batch effect-correction
methods. So, we also used COMBAT on D2.2H to
remove batch effects, and evaluate performance recovery
against the original D2.2 (where no batch effects are in-
troduced but class effects are). COMBAT is a well-
known batch effect-correction approach and employs
empirical Bayes frameworks for adjusting data for batch
effects. It is reported to be robust to outliers in small
sample sizes (<25) while maintaining comparable per-
formance to existing methods for large samples [25].
Statistical feature-selection methods
Four classes of feature-selection methods are tested to
see whether they are robust against batch effects (i.e.,
they do not select features that are associated with
batch). The standard Single-Protein t-test (SP) [26] and
Hypergeometric Enrichment (HE) [4] test are the most
commonly used comparative analysis methods. We have
also included two variants of rank-based network algo-
rithms (RBNAs)—viz. SubNETs (SNET) [27] and Fuzzy-
SubNETs (FSNET) [23]—which were demonstrated to
be highly stable and reliable [14] (Additional file 1).
On real data, HE, SNET and FSNET are tested using
CORUM complexes [28] as their protein complex-based
feature vector [16, 17, 29]. The performance of these
feature-selection methods are evaluated on precision
and recall (Additional file 1).
On simulated data (D2.2 and D2.2H, without and with
simulated batch effects respectively), these same
methods are evaluated based on simulated complexes
(pseudo-complexes). In simulated data, the differential
proteins are known a priori. We use these to create
true-positive pseudo-complexes. To achieve this, a
Euclidean distance is first determined for all differential
protein pairs across all samples. These are then clustered
via Ward’s linkage. Differential proteins are reordered
such that those with similar expression pattern (across
samples) are adjacent to each other. This reordered list
is then split at regular intervals to generate 101 true-
positive pseudo-complexes. An equal number of non-
significant proteins is randomly selected, reordered
based on expressional correlation, and then split to gen-
erate an equal number of true-negative pseudo-
complexes.
We may alter the “purity” of the true-positive pseudo-
complexes by reducing the proportion of differential
proteins within them. In practice, we seldom observe all
complex members being differentially expressed simul-
taneously (which also renders it too easy for detection).
Purity, therefore, is the proportion of differential pro-
teins within each true-positive pseudo-complex. At
100% purity, simulated complexes are comprised solely
of significant proteins; at 75% purity, 25% of the con-
stituent significant proteins are randomly replaced with
non-significant ones; and so on. Reducing purity permits
evaluation of the robustness and sensitivity of the
complex-based analysis methods. Purity is tested at three
levels: 100, 75 and 50%.
The true-positive and true-negative pseudo-complexes
are combined into a single vector. Evaluation is based on
the F-score.
Results and discussion
Batch effects cannot be completely eradicated via batch
effect-correction algorithms
Our method simulates batch effects in the following
manner (Fig. 1a): In the first dimension, class-effect sizes
are inserted based on the method of Langley and Mayr
to distinguish classes D and D* [24]. Class-effect sizes
are sampled randomly from five possibilities and
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inserted into randomly selected variables on samples be-
longing to class D*, constituting 20% of all variables.
This is repeated to generate 100 random datasets (D2.2).
In the second dimension, for each of the 100 datasets,
batch effects are inserted over all variables. Here, batch
effects are simulated by taking half the members in D
and D* to be batch 1, and the remaining half as batch 2.
Batch effects are not evenly applied across all variables,
and thus cannot be eradicated via simple normalization
[10]. To simulate batch effects unevenly, heterogeneity/
batch-effect sizes, like class-effect sizes, are also sampled
randomly from the same five possibilities. However, we
make the assumption that batch effects influence all var-
iables in a sample, and thus expect batch effects to ac-
count for a majority of variation. These 100 simulated
datasets, D2.2.301H to D2.2.400H are available for
download from Additional file 2.
To understand how batch effects affect feature selec-
tion, we compare precision, recall and F-score based on
the standard t-test, with and without multiple-test cor-
rection based on the Benjamini-Hochberg False
Discovery Rate (FDR) (Fig. 2). The first two columns in
Fig. 2 reveal that incorporation of batch effects increases
the variability of performance metrics, with particular
impact on recall, and reduces overall performance (viz.
F-score). While we expect different feature-selection
methods, aside from the t-test, may respond differently
to batch effects, it is useful to incorporate heterogeneity/
noise simulations during performance evaluation.
The commonly used batch effect-correction method,
COMBAT [25], only partially recovers original test per-
formance (without batch effects). Therefore, it does not
completely eradicate heterogeneity. Additionally, while it
improves overall performance, it also tends to reduce
precision, incorporating false positives into the selected
feature set. This is cause for concern during selection of
features for experimental validation. In the non-FDR
corrected scenario, COMBAT also does not perform bet-
ter than conventional data normalization methods, e.g.,
quantile normalization and linear-scaling (Fig. 2). How-
ever, when test requirements are more stringent given
the 5% FDR cutoff, then it is clear that COMBAT


















































































































Fig. 1 a Simulations: From single-class data, samples are split randomly into two classes D and D*. Class effects are randomly inserted into
proteins in D*. This is followed by insertion of batch effects. b PC manipulation: Proteins are sorted based on variance followed by a cutoff. The
retained expression data is analyzed via principal component analysis (PCA). The first principal component (PC1) corresponds strongly to batch
effects and may be removed. c Manipulation of PCs for clustering and class prediction. When combined with data of unknown labels, class labels
can be predicted based on co-clustering with samples of known labels
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Fig. 2 (See legend on next page.)
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provides considerable advantage (over both quantile
normalization and linear-scaling).
In spite of the simplicity of these simulations, it is note-
worthy that batch effect-removal (and normalization)
methods are not a panacea. We cannot declare COMBAT
is inferior, but rather, we will never know if batch effects
have been effectively removed from real data, particularly
when the data happens not to fit COMBAT’s assumptions
well. Thus, a naïve reliance on batch effect-correction al-
gorithms, without conducting further downstream checks
for remnant batch effects (if possible), may potentially
worsen analytical outcome.
A relook at principal component analysis for detecting
and removing batch effects
Principal component analysis (PCA) yields linear combi-
nations of each variable’s contribution to variance, but
evidently not all variables are equally interesting or rele-
vant (which necessitates feature selection in the first
place): We may say the features that changed the most,
i.e., exhibited the most variation, are likely more impact-
ful (contributing strongly to class or batch effects, or
both). Although we may not know this first-up for every
feature, we can still reduce the feature set size via
variance-based pre-selection. Here, a cutoff is introduced
to include only the top 20% proteins (ranked by vari-
ance) and used in PCA (Fig. 1b).
As stated earlier, PCA is commonly used for visualiz-
ing batch effects. A simple way to do this is to label sam-
ples by classes (D and D*) and batches (rep 1 and 2),
and diagrammatize these as scatterplots across the first
2 or 3 principal components (PCs). In Fig. 3a, the PCs
are based on the top 20% proteins (ranked by variance)
and evidently, this is sufficient for detecting batch ef-
fects. It is therefore unnecessary to use all variables
(Additional file 3). However, it is unclear whether this is
sufficient for detecting class effects.
Scatterplots, being rough visual guides, do not reveal
well the contributions of class and batch effects to each
PC. In our opinion, paired boxplots (splitting each PC
by class and batch) are more informative and, here, it is
evident that PC1 and PC2 correspond to batch and class
effects respectively (Fig. 3b).
When a batch effect is observed, it is common practice
to apply a batch effect-removal or –correction method
(e.g., COMBAT [9]). However, this does not necessarily
work well in practice. Moreover, if the data does not fit
the correction method’s assumptions, it may lead to false
positives. Instead, we may opt for a more direct strategy
by simply removing the first PC (Fig. 1b), and deploying
the remaining PCs as features for analysis. When PC1
contributes strongly to batch effects, its removal should
allow class effects to become the dominating source of
variation (Fig. 4a).
Using two examples (D2.2. 301H and 302H), we show
that removal of the first PC (PC1) allows samples to
cluster based on classes rather than batch (Fig. 4a). A
caveat is that removal of PC1 works here primarily be-
cause it is strongly correlated with batch effects; i.e.,
batch effects account for the majority of variance in the
data. On real data, it may necessitate the removal of sev-
eral other PCs that are correlated with batch effects.
Moreover, if incompletely eradicated or inseparable from
class effects, batch effects may resurface in subsequent
PCs (after PC1) during analysis (See section “Variable-
selection methods with resistance to batch/heterogeneity
effects”).
Suppose that removal of the first n PCs results in good
class separation in PCA, it may be possible to use the
remaining PCs for feature selection and non-projection-
based clustering techniques, e.g., hierarchical clustering
and k-means. This may seem counter-intuitive, as during
standard analysis involving PCA, it is common to keep
just the top n PCs accounting for the majority of vari-
ation. But not all variation is attributable towards class
effects (even if it is large). Moreover, PCs with large
same-sign coefficients tend to represent non-class effect
properties correlated with the variables; e.g., Tsuchiya et
al. demonstrated that, for their dataset, PC1 is linearly
correlated with the magnitude of average gene
expression [30]. On the other hand, subsequent PCs
with lower contribution towards overall variation may be
dominated by small subsets of variables with good class-
discrimination power [13]. Thus, instead of discarding
the lower ranked PCs, it is more reasonable to remove
the top PCs that are non-correlated with class effects.
We find that subsequent PCs do correlate strongly with
sample classes D and D* (Fig. 4a), and may be used as
variables for clustering (Fig. 4b).
A PC-based feature-selection approach is viable and
allows relevant proteins to be retraced. This is executed
(See figure on previous page.)
Fig. 2 Batch effect-correction does not work optimally in practice. Top row: Feature selection without multiple-test correction. Bottom row:
Feature selection with FDR correction. First column shows base performance with only class effects (No batch). Second column shows performance
with batch effects incorporated. Third, fourth and fifth columns show recovery using various batch effect-correction methods, (COMBAT, quantile
normalization and linear-scaling). Feature-selection test used here is the two-sample t-test (Abbreviations: P, Precision; R, Recall; F, F-score)
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by first identifying the PC of interest, and selecting pro-
teins that contribute exclusively and strongly to it [13].
As a simple test, we look at two scenarios using
D2.2.301H and D2.2.302H. In the first scenario, pro-
teins strongly associated with PC1 (without PC1 re-
moval) are selected. We term this “PC1” (see Table 1).
In the second scenario, we removed the original PC1,
and looked at proteins strongly associated with the new
PC1 (the new PC1 is computed on the reduced data
where those proteins strongly associated with the ori-
ginal PC1 are removed). This is termed “–PC1” (see
Table 1). Since the original PC1 is strongly associated
data_top20var
































































































































Fig. 3 a 3D-Principal Component Scatterplot Analysis: Batch effects dominate in the simulated data. Shown are two examples D2.2.301H and
D2.2.302H. b PC-paired boxplots: Each PC may be split by class and batch, and compared against each other as side-by-side boxplots. This allows
easy evaluation of the contribution of class and batch effects to each PC
































































































































































































































































Fig. 4 (See legend on next page.)
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with batch effects, its associated proteins are therefore
less relevant, and we expect that performing feature se-
lection on these using the t-test, and evaluating the cor-
responding precision, recall and F-score should fare
worse than those proteins associated with the new PC1.
We find the results following PC1 removal are similar
to batch effect-correction algorithms, with concomitant
increase in recall following removal of the first princi-
pal component (Table 1). As a parallel test, we calculate
a t-statistic for each protein under consideration, rank
them from the highest to lowest, and keep only the top
n proteins, where n = same number of proteins associ-
ated with –PC1 (termed “TT/-PC1” in Table 1). Inter-
estingly, these do worse (lower precision and recall),
and moreover, have limited overlaps with the –PC1 se-
lected features.
This procedure—viz. rank proteins by variance, per-
form PCA using the top 20%, discard PCs that are
strongly correlated with technical variables, and perform
e.g., clustering using the remaining PCs—may be used
for class prediction on new batches with unknown class
labels. A schematic is provided in Fig. 1c. And, to test
this, two different sets of batch effects are inserted into
D2.2.301, the first is (20, 50, 80, 100 and 200%), and the
second is (10%, 30%, 50%, 70%, 90%) (Fig. 4c), and the
data combined.
Expectedly, clustering based on all PCs show that
batch effects dominate. However, removal of PC1 re-
covers perfect class discrimination. This suggests that
even when combining several datasets with different
batch effects, removal of PC1 retains class effects, and
permits class prediction (Fig. 1c). Moreover, if we have
multiple datasets of the same disease, properly dealing
with batch effects makes it possible to pool these data-
sets for analysis. This is useful when larger sample sizes
are needed for ad hoc analysis.
Using variance-based variable pre-selection and principal
component manipulation to tackle real batch effects
To evaluate how the procedure above is applicable to-
wards real data, we consider the renal cancer study of
Guo et al., which contains two technical replicates (i.e.,
two batches, rep1 and rep2)[1]. This data, RC, has been
carefully processed; and batch effects appear contained
(Additional file 4).
We insert batch effects into RC rep2 (in the same
manner as D2.2H) (Fig. 5a). However, PC1 does not
purely contain variability from batch effects but also
some signal from class effects (Fig. 5b). As with D2.2H,
PC projection also reveals dominance of batch effects
(Fig. 5c) that may be controlled via removal of PC1
(Fig. 5d). However, it appears some remnant batch effect
still persists (Some rep2 D and D* samples still cluster
together).
Feature-selection methods with resistance to batch/
heterogeneity effects
There are remnant batch effects in RC (Fig. 5d) that are
difficult to eradicate, and may lead to bias during subse-
quent feature selection. When batch effects are strong,
then removal of the first few PCs is a useful direct strat-
egy, especially if information on batch and other poten-
tial confounding factors are not known a priori (i.e., we
cannot systematically eliminate non-class relevant vari-
ation) and batch effect-correction methods cannot be ef-
fectively deployed. On the other hand, it is not always
straightforward to interpret the PCs and extract the pro-
teins relevant for class effects. PC-based removal and
batch-effect correction also may not be able to remove
subtle batch effects.
As an additional note of caution, batch effect-removal
approaches—including the procedure described above—
may at times be overkill: These corrections may uninten-
tionally eliminate true biological heterogeneity amongst
samples (i.e., disease subpopulations), which is inform-
ative (e.g., identifying personalized signatures for deter-
mining therapy) and should not be discarded from the
Table 1 Effects on precision and recall for D2.2.301H and
D2.2.302H before and following removal of proteins with heavy
loadings on the first principal component (PC1 and − PC1
respectively)
Precision Recall F-score Jaccard
301H (PC1) 1.00 0.30 0.46
301H (-PC1) 1.00 0.35 0.52
301H (TT/-PC1) 0.65 0.23 0.34 0.48
302H (PC1) 0.94 0.32 0.48
302H (-PC1) 0.93 0.43 0.59
302H (TT/-PC1) 0.72 0.30 0.42 0.61
TT refers to the standard t-test while TT/-PC1 are the top n-ranked TT-features
(restricted to the number of features in –PC1). The Jaccard coefficient indicates
limited overlaps amongst the top TT-features associated with –PC1 features
(See figure on previous page.)
Fig. 4 a 3D-Principal Component Analysis: Class effects dominate in the simulated data, given the removal of PC1 (Two examples are shown:
D2.2.301 and D2.2.302). b Heatmaps and hierarchical clustering (HCL): The remaining PCs may also be used as individual variables for clustering,
and provide strong discrimination between classes D and D*. c Combining two datasets with different batch effects: Datasets A and B have the
same differential feature set but different batch effects. Combining these followed by analysis of all principal components (PC) shows batch
effects dominate. However, removal of PC1 perfectly recovers class-effect discrimination without having to perform any feature selection
(Notation: A/B_D/D*_1/2 refers to the dataset, class and batches respectively)
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data in the first place. Unfortunately, batch-effect and
subpopulations are not easy to tell apart [16]. And if we
run the PC-removal or other batch effect-correction
methods, subpopulation information is irrevocably lost.
On the other hand, high heterogeneity in the form of
multiple subpopulations can make analysis very challen-
ging, particularly in cancer proteomics [31].
One way forward is to incorporate robust data
normalization methods and biological context (e.g., net-
works and protein complexes) directly into feature-
selection approaches [29]. Recently, we expound on the
advantages of protein complexes as suitable biological
context in improving data analysis. Unlike analysis at the
level of proteins as features, the use of protein complexes
as features, leads to improve stability and reproducibility
[14, 15, 20, 21, 32, 33].
We are curious if the high performance of protein
complex-based methods belonging to the family known
as Rank-Based Network Analysis (RBNAs) exhibit super-
ior performance (high feature-selection reproducibility
and cross-validation prediction power) due to innate re-
sistance to batch effects [14, 23, 27]. There are several
reasons why we think RBNAs may be robust against
batch effects: Its score function uses rank-based
discretization instead of exact values, which is robust
against various biases, e.g., test-set bias [34]. Use of bio-
logical context (e.g., networks and complexes) increases





































































































































































































































































































Fig. 5 a Hierarchical Clustering (HCL) based on protein expression: Batch effects dominate here, as samples separate more strongly based on batch
than by class. No variable selection was performed prior. b Principal Components (PCs) 1 and 2 stratified by class and batch: Although PC1 is still
strongly associated with batch; there is also some association with class effects. In contrast, PC2 is strongly associated with class rather than with batch
effects. c HCL based on all PCs: In this case, it is clear that batch effects dominate. d HCL following PC1 removal: Removal of PC1 appears to eradicate
a large proportion of the batch effects. But this is incomplete, suggesting that there may still be ambient batch effects remaining
The Author(s) BMC Genomics 2017, 18(Suppl 2):142 Page 10 of 15
correlations (e.g., batch) as only signal from same-
complex members are summated. We already know that
use of protein complexes increases power, and we be-
lieve the signal amplification is phenotypically relevant
[35]. Previous tests have already demonstrated that
complex-based features are specifically predictive for
phenotype classes and that false-positive rates are low.
However, a specific investigation into batch-effect resist-
ance has not been done. Hence, we test two members:
SubNets (SNET) [27] and Fuzzy-SNET (FSNET) [23].
To test whether RBNAs are effective in overcoming
batch effects, as opposed to simply eliminating them, we
performed two sets of tests; the first on simulated data
(based on D2.2 and D2.2H) as a proof-of-concept and
the second on real data (using RC). Besides SNET [27]
and FSNET [23] (two representative RBNA methods),
we also include the standard single-protein t-test (SP)
[26, 36] and the hypergeometric enrichment test (HE)
[4]. SP is a control based on the standard univariate t-
test at the level of individual proteins. HE is an over-
representation-based technique meant to determine if
the differential proteins are significantly enriched in
some protein complex based on the hypergeometric test;
i.e., it uses the same protein complexes, but not the
same statistical test as the RBNAs.
Using D2.2 (no batch effects) and D2.2H (simulated
batch effects), we compare the F-scores across three pur-
ity levels (proportion of differential proteins within the
Fig. 6 Complex-based methods are robust against batch effects (simulations): Distribution of F-scores for SP, HE, SNET and FSNET in simulated
data where batch effects are absent or present based on the simulated complexes (pseudo-complexes) and individual proteins. Note that for SP,
the F-scores shown are always based on individual proteins (Abbreviations: Single-Protein t-test, SP; Hypergeometric Enrichment, HE; SubNET,
SNET; Fuzzy SNET; FSNET)
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pseudo-complexes), at both complex and individual pro-
tein levels (Fig. 6). We observe that the F-score for the
protein-based t-test (SP) is very low to begin with, but
progressively worsens when batch effects are introduced.
The hypergeometric enrichment (HE) pipeline uses the
same pseudo-complexes as the RBNAs, but also appears
to be sensitive to batch effects (especially at the complex
level). The RBNAs, SNET and FSNET, are resistant to
batch effects. At the complex level, there is almost no
difference in F-scores regardless of purity. This suggests
that the RBNAs are robust not only against the batch ef-
fects, but also decreasing differential signal as purity de-
creases. This finding is also corroborated at the level of
individual proteins as well.
Our findings are a positive indication that the RBNAs
are highly robust against weaker differential signal and
batch effects. Additionally, given HE’s poor performance,


















































































































Fig. 7 PC side-by-side boxplots stratified by class and batch tested on real data:, Rank-based network algorithms SNET and FSNET are against batch
effects, and only seems to capture variation stemming from class effects (Abbreviations: Single-Protein t-test, SP; Hypergeometric Enrichment, HE;
SubNET, SNET; Fuzzy SNET; FSNET)
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statistical test setup is also critical. This result is import-
ant as it is the first, to the best of our knowledge, to
demonstrate that complex-based feature-selection ap-
proaches are resilient against batch effects.
However, there are caveats: Firstly, these batch effects
are simulated, and unreflective of true batch effects. Sec-
ondly, these pseudo-complexes may not be good approx-
imations of true protein complexes. Although we cannot
test real data directly (the real differential proteins are
not known a priori), we may still evaluate these methods
(SP, HE, SNET and FSNET) on real data.
Using the original RC (where ambient batch effects per-
sist), we perform PCA on significant features selected by
the four feature-selection methods. For the first 3 PCs,
side-by-side boxplots stratified by class and batch (Fig. 7)
demonstrates that RBNAs (SNET and FSNET) are very
powerful, and appear to capture variation stemming only
from class effects. This is in contrast to SP, where batch ef-
fects still persist in PC2. HE is commonly used as a post-
hoc test following SP. It also takes advantage of the same
set of protein complexes as SNET and FSNET; but clearly,
this is insufficient (batch effects are relegated to PC3): The
method used for statistical testing also matters.
This finding is critical: Since RBNAs are robust against
batch effects, this obviates the need for performing data
transformations (e.g., PCA or batch-effect correction).
This also means that if subpopulations do exist in the
data, this information is retained. It should be noted that












































































































Fig. 8 Expression or network score-based (y-axis) side-by-side boxplots stratified by class and batch for top three variables: Rank-based network al-
gorithms, SNET and FSNET, can capture the class effects while robust against batch effects. Both class and batch variability is present in the top
variables selected by SP and HE (Abbreviations: Single Protein t-test, SP; Hypergeometric Enrichment, HE; SubNETs, SNET; Fuzzy SubNETs; FSNET)
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dealing with subpopulations is difficult and outside the
scope of this work, although we may also use complexes
for detailed in-depth study of subpopulations [16].
While RBNAs are evidently powerful against batch
effects, especially against subtle ones that cannot be
easily removed via removal of the first n PCs or via
batch effect-correction algorithms, they are not per-
fect solutions. E.g. methods such as FSNET weigh
each protein in a protein complex by the fraction of
subjects (in the relevant class) where the protein is
highly ranked. This fraction may be unstable from
subsample to subsample, particularly in the presence
of hidden subpopulations. This may reduce class-
specific signals, making it difficult to identify good-
quality and relevant features.
Downstream considerations post-analysis
Discarding batch effect-laden PCs is a transformation
that provides a transformed dataset with much reduced
batch effects. It helps identify strong class discriminatory
features. Yet, at the same time, new batches are not dir-
ectly comparable to this transformed dataset. So it is dif-
ficult to extract directly clinical guideline/thresholds for
future diagnostic use. For example, as a simple diagnos-
tic tool, one wants a protein X such that: If X’s abun-
dance is above a threshold y, then the patient is sick.
But, in the presence of batch effects, different thresholds
are needed for different batches. On the other hand, once
the good features are found, one may apply more reliable
technologies—i.e., ones that are less susceptible to batch
effects—to measure only those features specifically.
To test this empirically, the analysis in Fig. 7 is re-
peated. We plot the boxplots based on log-normalized
expression of significant proteins for SP and HE, and
scores of significant subnets for SNET and FSNET, for
the top three features (Fig. 8). For SP and HE, both class
and batch variation are detected amongst the top three
features. So it is reasonable to conclude that where these
approaches are concerned, it is difficult to identify class
discriminatory signal. The top three features selected by
SNET and FSNET (i.e., subnets) capture class effects bet-
ter, and appear robust against batch effects. Thus, we ex-
pect that use of these features for diagnostics will yield
better results.
Conclusions
The impact of batch effects in proteomics cannot be under-
stated, and has key implications in clinical and translational
research. We have shown that batch effect-correction algo-
rithms are not a panacea, and that the corrected data may
be erroneous. Moreover, with the development of any novel
feature-selection approach, it is worthwhile to test their
robustness against simulated batch effects.
We have illustrated that side-by-side barplots are bet-
ter for visually detecting batch effects than the standard
PCA scatterplot-based representation format. Moreover,
the PCs themselves may be used as features, which may
also be effectively traced back to relevant differential
proteins. This is also a viable strategy complementary to
batch effect-correction methods.
Unfortunately, subtle batch effects cannot be easily re-
moved or detected, and can lead to bias in the analysis of real
data. Moreover, data transformation may lead to the loss of
valuable subpopulation information. We confirm that one of
the reasons complex-based algorithms like the RBNAs are
successful is because they have innate resistance against
batch effects. This resistance stems from amplification of
phenotypic-relevant signal from same-complex members
and rank-based discretization of expression values (increasing
the signal from high confidence proteins while removing
noise from low confidence proteins). As RBNAs require no
prior data transformations, the integrity of the data is pre-
served (including subpopulation information). Finally indi-
vidual check on the top features selected by RBNAs
confirms that they are strongly associated with class and not
batch effects. This means that features selected in this man-
ner are more likely to be clinically useful.
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